Uniqure NV UQ1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 6:42 PM CEST
25.47quote price arrow down-1.78 (-6.53%)
52 week range
24.40 - 61.44

...

Loading . . .
  • Open25.41
  • Day High25.73
  • Day Low25.13
  • Prev Close27.25
  • 52 Week High61.44
  • 52 Week High Date06/23/20
  • 52 Week Low24.40
  • 52 Week Low Date03/29/21

Key Stats

  • Market Cap1,509.77M
  • Shares Out45.92M
  • 10 Day Average Volume225.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.25

KEY STATS

  • Open25.41
  • Day High25.73
  • Day Low25.13
  • Prev Close27.25
  • 52 Week High61.44
  • 52 Week High Date06/23/20
  • 52 Week Low24.40
  • 52 Week Low Date03/29/21
  • Market Cap1,509.77M
  • Shares Out45.92M
  • 10 Day Average Volume225.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.25

RATIOS/PROFITABILITY

  • EPS (TTM)-2.64
  • P/E (TTM)-9.65
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Uniqure NV

There is no recent news for this security.

Profile

MORE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing...
Philip Astley-Sparke
Non-Executive Chairman
Matthew Kapusta CPA
Chief Executive Officer
Pierre Caloz
Chief Operating Officer
Christian Klemt CPA
Chief Accounting Officer
Alexander Kuta Ph.D., III
Executive Vice President
Address
Paasheuvelweg 25a
Amsterdam
1105 BP
Netherlands